NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Brachytherapy



Investigators at McGill University publish new data on brachytherapy



December 23rd, 2008

"An integrated software platform was developed to perform a patient-specific dosimetric study on high-dose-rate Ir-192 endorectal brachytherapy. Monte Carlo techniques were used to examine the perturbation effects of an eight-channel intracavitary applicator with shielding and a liquid-inflatable balloon," investigators in Montreal, Canada report.

"Such effects are ignored in conventional treatment planning systems that assume water-equivalent geometries. A total of 40 Task Group 43-based rectal patient plans were calculated using the PTRAN_CT Monte Carlo photon transport code. The silicone applicator, tungsten or lead shielding, contrast solution-filled balloon, and...


Source: Cancer Weekly (2008-12-23)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login